These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 18445902

  • 21. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
    Falqui V, Viazzi F, Leoncini G, Ratto E, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R.
    J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
    [Abstract] [Full Text] [Related]

  • 22. A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
    Bello AK, Peters J, Wight J, de Zeeuw D, El Nahas M, European Kidney Institute.
    Am J Kidney Dis; 2008 Sep; 52(3):434-43. PubMed ID: 18725014
    [Abstract] [Full Text] [Related]

  • 23. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
    Gerstein HC, Mann JF, Pogue J, Dinneen SF, Hallé JP, Hoogwerf B, Joyce C, Rashkow A, Young J, Zinman B, Yusuf S.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B35-9. PubMed ID: 10860189
    [Abstract] [Full Text] [Related]

  • 24. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C, Meani S, Salerno M, Severgnini B, Fusi V, Valerio C, Catini E, Magrini F, Zanchetti A.
    Blood Press; 2004 May; 13(3):144-51. PubMed ID: 15223722
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Target organ damage and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility.
    Ayodele OE, Alebiosu CO, Akinwusi PO, Akinsola A, Mejiuni A.
    Niger J Clin Pract; 2007 Dec; 10(4):319-25. PubMed ID: 18293643
    [Abstract] [Full Text] [Related]

  • 33. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy.
    Biesenbach G, Zazgornik J.
    Clin Nephrol; 1994 Apr; 41(4):211-8. PubMed ID: 8026113
    [Abstract] [Full Text] [Related]

  • 34. Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients.
    Cuspidi C, Meani S, Valerio C, Esposito A, Sala C, Maisaidi M, Zanchetti A, Mancia G.
    J Hum Hypertens; 2007 Jul; 21(7):531-8. PubMed ID: 17429446
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.